歡迎網友自由發表文章，但嚴禁發表有關相互人身攻擊言論、廣告文章、任何交易買賣 、或與本站主題不相關的文章。
請勿連續發表相同文章，關於討論區內的所有文章，本站皆擁有刪除及修改文章的權利。

回應討論主題
回應主題：
您的稱呼：
您的性別：
您的職業：
來自何方：
電子信箱：
您的首頁：
留言筆色：
討論內容： We'd like to invite you for an interview http://weimaracademy.org/campus_life ivermectine tabletten (stromectol) ?糧????3 mg Investigations into alleged irregularities at Kazakh-focused ENRC, listed in London in 2007, and Indonesia-orientated Bumi, listed in 2011, have put a spotlight on these issues. Both were hit by shareholder battles that have battered their shares, raising questions about how they came to market.

留言內容：